Product Name | Ginsenoside Rh1 |
---|---|
CAS | 63223-86-9 |
Formula | C36H62O9 |
MW | 638.87 |
Appearance | 白色粉末 |
Boiling point | 755.1±60.0 °C | Condition: Press: 760 Torr |
PKa | 12.91±0.70 | Condition: Most Acidic Temp: 25 °C |
Product Name | Ginsenoside Rh1 |
---|---|
CAS | 63223-86-9 |
Formula | C36H62O9 |
MW | 638.87 |
Appearance | 白色粉末 |
Boiling point | 755.1±60.0 °C | Condition: Press: 760 Torr |
PKa | 12.91±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000473
中文名稱(chēng):人參皂苷Rh1
中文別名:人參皂甙Rh1;S-人參皂苷Rh1;(S型)人參皂苷Rh1;20(S)-人參皂苷Rh1;(20S)-人參皂苷Rh1;(2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-二羥基-17-((S)-2-羥基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氫-1H-環(huán)戊[a]菲-6-基)氧基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇
英文名稱(chēng):Ginsenoside Rh1
英文別名:(3β,6α,12β)-3,12,20-Trihydroxydammar-24-en-6-yl β-D-glucopyranoside;Dammarane, β-D-glucopyranoside deriv.;20(S)-Ginsenoside Rh1;Ginsenoside Rh1;Prosapogenin A2;Rh1 ginsenoside;Rh1 ginsenoside;S-Ginsenoside Rh1;Sanchinoside B2;Sanchinoside Rh1;
分子式:C36H62O9
分子量:638.87
CAS號(hào):63223-86-9
純度:HPLC≥98%
沸點(diǎn):755.1±60.0 °C | Condition: Press: 760 Torr
密度:1.23±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù):12.91±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件:-20℃,干燥、避光、密封
規(guī)格:5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶(hù)需求包裝
供應(yīng)單位:四川省維克奇生物科技有限公司
供應(yīng)電話:028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類(lèi)標(biāo)準(zhǔn)品和天然植物有效單體,主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體,化學(xué)合成,抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲(chóng)草系列等,敬請(qǐng)關(guān)注! 新批次有現(xiàn)貨,歡迎咨詢(xún)。
Steamed Panax notoginseng attenuates renal anemia in an adenine-induced mouse model of chronic kidney disease | ||
Source:SCI:JOURNAL OF ETHNOPHARMACOLOGY | Author:Min Gao | Notes:影響因子:4.36 |
Reference description | ||
The reference standards of notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rc, 20(S)–Rh1, 20(R)-Rh1, Rd, Rg6, F4, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5, all with a purity ≥98%, were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). EPO was purchased from Chengdu Di'ao Jiuhong Pharmaceutical Factory (Chengdu, Sichuan, China). FEJ was purchased from Shandong Dong'e E'jiao Co., Ltd. |
Rapid characterization and determination of isoflavones and triterpenoid saponins in Fu-Zhu-Jiang-Tang tablets using UHPLC-Q-TOF/MS and HPLC-UV | ||
Source:SCI:Analytical Methods | Author:Yi Tao | Notes:影響因子:1.915 |
Reference description | ||
3′-Hydroxypuerarin, puerarin, 3′-methoxypuerarin, mirificin, daidzin and daidzein were obtained from Chengdu Purechem-standard Co. Ginsenoside Rg1, ginsenoside Rh1, ginsenoside Rd, astragaloside IV and 20(S)-ginsenoside Rg3 were purchased from Chendu Herbpurify Co. Astragalin was obtained from Sichuan Weikeqi Biotechnology Co. Linoleic acid and palmitic acid were purchased from Shanghai Ryon Biological Technology Co. HPLC-grade acetonitrile was obtained from Merck Co. |
An integrated strategy of MS-network-based offline 2DLC-QTOF-MS/MS coupled with UHPLC-QTRAP®-MS/MS for the characterization and quantification of the non-polysaccharides in Sijunzi decoction | ||
Source:SCI:ANALYTICAL AND BIOANALYTICAL CHEMISTRY | Author:Dong, Bangjian | Notes:影響因子:4.157 |
Reference description | ||
Liquiritin apioside, liquiritin, neoliquiritin, isoliquiritin apioside, isoliquiritin, ononin, naringin, liquiritigenin, poricoic acid A, poricoic acid B, poricoic acid C, glycyrrhetinic acid, dehydropachymic acid, pachymic acid, ginsenoside Re, ginsenoside Rg1, ginsenoside Rf, isoliquiritigenin, ginsenoside Rb1, ginsenoside Rg2, ginsenoside Rg3, ginsenoside Rg5, 20(S)-ginsenoside Rh1, notoginsenoside R1, ginsenoside Ro, ginsenoside Rc, formononetin, ginsenoside Rb2, glycyrrhizic acid, ginsenoside Rd, ginsenoside Rk1, and atractylenolide III were purchased from Chengdu DeSiTe Biological Technology Co., Ltd. (Chengdu, China) or Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, China). |
Effect of steam-processing of the Panax ginseng root on its inducible activity on granulocyte-colony stimulating factor secretion in intestinal epithelial cells in vitro | ||
Source:SCI:JOURNAL OF ETHNOPHARMACOLOGY | Author:Kewen Ding | Notes:影響因子:4.36 |
Reference description | ||
Isomaltose was purchased from Tokyo Chemical Industry (Tokyo, Japan). Protopanaxatriol and protopanaxadiol were obtained from ChromaDex (Irvine, CA). Compound K, ginsenosides Rh1, Rd, F1, F2, Rg3, and Rh2 were obtained from Sichuan Weikeqi Biological Technology (Chengdu, Sichuam, China). Lectin from Phytolacca americana (pokeweed mitogen, PWM), dextran standards certified according to Deutsches Institut für Normung (molecular weight; 668 kDa), Dulbecco’s modified Eagle’s medium |
Steamed Panax notoginseng Attenuates Anemia in Mice With Blood Deficiency Syndrome via Regulating Hematopoietic Factors and JAK-STAT Pathway | ||
Source:SCI:Frontiers in Pharmacology | Author:Yin Xiong, | Notes:影響因子:4.225 |
Reference description | ||
Qualitative and quantitative analyses of SPN were performed as previous report (Xiong et al., 2017a). In brief, notoginsenoside R1 and ginsenosides Rg1, Re, 20(R)-Rh1, Rb1, Rd, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Sichuan, China) with purity ≧ 98% were used as standard compounds. The analysis was performed on an Agilent 1260HPLC system (Agilent Technologies) equipped with a G1311B Pump, a G4212B DAD detector, and a G1329B autosampler. |
Structure–inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs) | ||
Source:SCI:TOXICOLOGY AND APPLIED PHARMACOLOGY | Author:Zhong-Ze Fang | Notes:影響因子:3.975 |
Reference description | ||
Recombinant human UGT isoforms (UGT1A1, UGT1A6, UGT1A7, UGT1A8, UGT1A9, UGT1A10, UGT2B7, UGT2B15) expressed in baculovirus-infected insect cells were obtained from BD Gentest Corp. (Woburn, MA, USA). Ginsenosides Rb1, Rb2, Rc, Rd, Rg3, Rh2, C-K, ppd, ppt, Re, Rg1, Rh1, F1, and F2 were purchased from Sichuan Weikeqi Biotechnology Company (Chengdu, Sichuan, China). The purity of these compounds was above 95%. All other reagents were of HPLC grade or of the highest grade commercially available. |
Optimisation of Ethanol-Reflux Extraction of Saponins from Steamed Panax notoginseng by Response Surface Methodology and Evaluation of Hematopoiesis Effect | ||
Source:SCI:MOLECULES | Author:Yupiao Hu | Notes:影響因子:3.098 |
Reference description | ||
Acetonitrile of chromatographic grade and ferrous chloride and hydrogen peroxide of analytical grade were purchased from Merck Chemical Co. (Darmstadt, Germany). Notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rd, Rh1, Rk3, Rh4, 20(S)-Rg3, and 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Chengdu, China) with a purity ≥ 98% were used as the standard compounds. |
Effect of ninjin’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice | ||
Source:SCI:Journal of Natural Medicines | Author:Suzuki, Toshiaki | Notes:影響因子:1.982 |
Reference description | ||
The water layer was further partitioned with water-saturated BuOH three times, yielding the BuOH and water fractions (0.20 and 4.4 g, respectively). Ginsenosides F1, F2, Rd, Rg3, Rh1, Rh2, protopanaxadiol, and protopanaxatriol were obtained from Sichuan Weikeqi Biological Technology (Chengdu, Sichuan, China); ginsenosides Rg1 and Rb1 were obtained from Wako Pure Chemical Industries (Osaka, Japan) |
Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1 | ||
Source:SCI:Journal of Natural Medicines | Author:Gao, Shengli | Notes:影響因子:1.67 |
Reference description | ||
Ginsenosides Rg1 and Rb1 were obtained from Wako Pure Reagents (Osaka). Compound K was obtained from ChromaDex (Irvine, CA, USA). Ginsenosides F1, F2, Rd, Rg3, Rh1, Rh2, protopanaxadiol and protopanaxatriol were obtained from Sichuan Weikeqi Biological Technology (Chengdu, Sichuam, China). Chemical structures of ginsenosides used in the present study are shown in Fig. 1. |
Ninjin’yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells | ||
Source:SCI:Journal of Natural Medicines | Author:Suzuki, Toshiaki | Notes:影響因子:1.593 |
Reference description | ||
Ginsenosides Rg1 and Rb1 were obtained from Wako Pure Reagents (Osaka, Japan). Compound K was obtained from ChromaDex (Irvine, CA). Ginsenosides Rd, Rh1, F1, and F2 were obtained from Sichuan Weikeqi Biological Technology (Chengdu, Sichuam, China). The chemical structures of these ginsenosides are shown in Fig. 2. |